Published in Food and Drug Law Weekly, January 27th, 2006
Shipments of the product will commence immediately.
Apotex' zonisamide is available in 100-count bottles, and is the generic equivalent of Eisai's Zonegran used to treat epilepsy. Annual sales for the brand are approximately $174 million.
The Apotex Group manufactures oral solids, liquids, injectables, nasal sprays, ophthalmics and inhalation solutions.
Zonegran is a registered trademark of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.